- Trials with a EudraCT protocol (16)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
16 result(s) found for: Aprotinin.
Displaying page 1 of 1.
EudraCT Number: 2005-003053-26 | Sponsor Protocol Number: TMC-BIV-05-01 | Start Date*: 2005-12-08 |
Sponsor Name:The Medicines Company UK Ltd | ||
Full Title: The ZBMUF trial: an open-label randomised study of the effects of ultra-filtration and high dose aprotinin on bivalirudin pharmacokinetics during and/or after cardiopulmonary bypass surgery | ||
Medical condition: This trial will involve approximately 42 patients requiring coronary artery bypass graft surgery (CABG). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004689-18 | Sponsor Protocol Number: Bay a 0128/11800 | Start Date*: 2006-06-28 | |||||||||||
Sponsor Name:Bayer Inc. | |||||||||||||
Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedu... | |||||||||||||
Medical condition: Thoracic surgery in patient with lung or esophageal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) DK (Prematurely Ended) ES (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003999-38 | Sponsor Protocol Number: Bay a 0128/11799 | Start Date*: 2006-04-06 | |||||||||||
Sponsor Name:Bayer Pharmaceuticals Corporation | |||||||||||||
Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal ... | |||||||||||||
Medical condition: Elective Spinal Fusion Surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004055-35 | Sponsor Protocol Number: Bay a 0128/12002 | Start Date*: 2006-01-02 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A multi-center, randomized, double blind, placebo controlled study to investigate the efficacy and safety of Aprotinin on transfusion requirements in patients with bladder cancer undergoing radical... | |||||||||||||
Medical condition: Radical or total cystectomy on patients with bladder cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Completed) SE (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002434-33 | Sponsor Protocol Number: Aprotinin1.0. | Start Date*: 2020-10-16 |
Sponsor Name:Hospital General Universitario Ciudad Real | ||
Full Title: Phase 3 randomized study to evaluate the safety and efficacy of aprotinin (Trasylol®) administered by inhalation nebulization in patients diagnosed with SARS-CoV-2 (COVID-19) with moderate severity... | ||
Medical condition: Patients with moderate SARS-CoV-2 pneumonia confirmed with a diagnosis of polymerase chain reaction (PCR) before randomization. The patient should be hospitalized and require ongoing medical care f... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002652-42 | Sponsor Protocol Number: 2007IC007H | Start Date*: 2007-08-14 | |||||||||||
Sponsor Name:Royal Brompton and Harefield NHS Trsut | |||||||||||||
Full Title: The use of clopidogrel and aprotonin in off pump coronary artery bypass grafting | |||||||||||||
Medical condition: Bleeding after coronary artery bypass grafting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018480-42 | Sponsor Protocol Number: 550904 | Start Date*: 2010-11-12 | ||||||||||||||||
Sponsor Name:Baxter Innovations GmbH | ||||||||||||||||||
Full Title: A RANDOMIZED, CONTROLLED, MULTICENTER PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FIBRIN SEALANT VH S/D 500 S-APR (TISSEEL) FOR HEMOSTASIS IN SUBJECTS UNDERGOING HEPATIC RESECTION | ||||||||||||||||||
Medical condition: Hemostasis in hepatic resection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-017804-95 | Sponsor Protocol Number: ATRHEMOS/1 | Start Date*: 2010-03-05 |
Sponsor Name:Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau | ||
Full Title: Prevención del sangrado postoperatorio: Ensayo clínico unicéntrico, aleatorizado, paralelo y controlado que evalúa la eficacia de la cola de fibrina y el ácido tranexámico en pacientes intervenidos... | ||
Medical condition: Pacientes que precisan de una artroplastia de rodilla. Patients with are needed of an arthroplasty of the knee. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004113-96 | Sponsor Protocol Number: AGO/2008/008 | Start Date*: 2008-09-17 |
Sponsor Name:University Hospital Ghent | ||
Full Title: DRainage versus sEAlant in prospective, Monocentric, double blinded randomized trial to evaluate the effect of fibrin glue in surgical repair of incisional hernias (DREAM-trial) | ||
Medical condition: Open incisional hernia mesh repair | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005535-40 | Sponsor Protocol Number: 3599-001 | Start Date*: 2016-07-21 | |||||||||||
Sponsor Name:Baxter Healthcare Corporation | |||||||||||||
Full Title: A Randomised Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated (FS VH S/D 500 s-apr) Compared to DuraSeal Dural Sealant as an Adjunct ... | |||||||||||||
Medical condition: Intra-operative CSF leak | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) ES (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002328-34 | Sponsor Protocol Number: KB056 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:KEDRION S.P.A | |||||||||||||
Full Title: Efficacy and safety evaluation of Kedrion Fibrin Sealant as an adjuvant for the control of hemostasis in pediatric patients undergoing abdominal or orthopedic surgery. Multicenter, randomized, cont... | |||||||||||||
Medical condition: Paediatric patients undergoing abdominal or orthopedic surgery | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001739-28 | Sponsor Protocol Number: S63979 | Start Date*: 2020-05-20 | |||||||||||
Sponsor Name:UZLeuven | |||||||||||||
Full Title: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19. | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003006-98 | Sponsor Protocol Number: PROT-TISSUCOL-001 | Start Date*: 2007-07-16 | |||||||||||
Sponsor Name:Cirugía General II. Hospital General Universitario “Gregorio Marañón” | |||||||||||||
Full Title: ESTUDIO FASE IV, UNICENTRICO, ALEATORIZADO, SIMPLE CIEGO, CONTROLADO, COMPARATIVO DE DOS GRUPOS PARALELOS PARA EVALUAR LA EFICACIA DE TISSUCOL DUO (ADHESIVO BIOLOGICO A BASE DE FIBRINA) EN LA PREVE... | |||||||||||||
Medical condition: Defectos de cicatrización (fístulas, dehiscencias y fugas subclínicas) en la(s) anastomosis(s) de tubo digestivo de alto riesgo: Las anastomosis consideradas de alto riesgo son: 1. Anastomosis rect... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001340-21 | Sponsor Protocol Number: KB046 | Start Date*: 2013-01-15 |
Sponsor Name:KEDRION | ||
Full Title: A Historically-Controlled Phase II/III study to Evaluate Efficacy and Safety of Kedrion Human Plasminogen Eye Drop Preparation in Patients Diagnosed with Ligneous Conjunctivitis | ||
Medical condition: Ligneous Conjunctivitis ( MedDRA Code vers. 15.0: 10071570 LLT - no present in OsSC database) associated with Type I Plasminogen Deficiency | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-004866-14 | Sponsor Protocol Number: | Start Date*: 2006-10-09 | |||||||||||
Sponsor Name:TAYS | |||||||||||||
Full Title: Aprotiinin keuhkojen toimintaa suojaava vaikutus sydänleikkauksissa | |||||||||||||
Medical condition: ohitusleikkaus | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002741-39 | Sponsor Protocol Number: TIMELI001 | Start Date*: 2005-12-07 | |||||||||||
Sponsor Name:Prof. Giampiero CAMPANELLI | |||||||||||||
Full Title: A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal he... | |||||||||||||
Medical condition: Unilateral, uncomplicated primary inguinal hernia repair | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
